Westford, MA, United States of America

Jun Tian

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Jun Tian: Innovator in Cell Bioproduction

Introduction

Jun Tian is a prominent inventor based in Westford, MA (US). He has made significant contributions to the field of cell bioproduction, holding a total of 6 patents. His work focuses on enhancing the quality and efficiency of mammalian cell cultures, which are crucial for pharmaceutical development.

Latest Patents

One of Jun Tian's latest patents is titled "Use of rosmarinic acid in cell bioproduction." This invention relates to new methods and processes for culturing mammalian cells with the addition of phenolic antioxidants. The performance of these cell culturing methods results in a higher viable cell density and higher protein titer. Another notable patent is "Methods of decreasing the galactose content of a recombinant glycoprotein expressed in CHO cells." This invention involves growing CHO cells expressing a recombinant polypeptide of interest in optimized media to manipulate and control the protein quality attributes of the polypeptides. These polypeptides can be advantageously used in the preparation of pharmaceutical compositions.

Career Highlights

Jun Tian is currently employed at Bristol-Myers Squibb Company, where he continues to innovate in the field of biopharmaceuticals. His work has been instrumental in advancing methodologies that improve cell culture processes, which are vital for drug development and production.

Collaborations

Throughout his career, Jun Tian has collaborated with notable colleagues, including Jianlin Xu and Qin He. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Jun Tian's contributions to cell bioproduction exemplify the impact of innovative thinking in the pharmaceutical industry. His patents reflect a commitment to improving cell culture techniques, which are essential for the development of effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…